These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11716094)

  • 1. Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein.
    Pryor MJ; Carr JM; Hocking H; Davidson AD; Li P; Wright PJ
    Am J Trop Med Hyg; 2001 Nov; 65(5):427-34. PubMed ID: 11716094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type 1 virus.
    Duarte dos Santos CN; Frenkiel MP; Courageot MP; Rocha CF; Vazeille-Falcoz MC; Wien MW; Rey FA; Deubel V; Desprès P
    Virology; 2000 Sep; 274(2):292-308. PubMed ID: 10964773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH.
    Guirakhoo F; Hunt AR; Lewis JG; Roehrig JT
    Virology; 1993 May; 194(1):219-23. PubMed ID: 8480420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of dengue-1 virus envelope glycoprotein gene sequences from French Polynesia.
    Laille M; Roche C
    Am J Trop Med Hyg; 2004 Oct; 71(4):478-84. PubMed ID: 15516646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recombinant envelope glycoprotein domain III of dengue virus inhibit virus infection].
    Lu P; Wei Y; Cao SC; Li JD; Liu QZ; Zhang QF; Li C; Miao F; Zhang S; Hang XT; Liang MF; Li DX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):177-9. PubMed ID: 19031695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites.
    Johnson AJ; Guirakhoo F; Roehrig JT
    Virology; 1994 Sep; 203(2):241-9. PubMed ID: 8053148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of two phenotypically distinct dengue type-2 virus isolates from the same dengue hemorrhagic Fever patient.
    Kinoshita H; Mathenge EG; Hung NT; Huong VT; Kumatori A; Yu F; Parquet MC; Inoue S; Matias RR; Natividad FF; Morita K; Hasebe F
    Jpn J Infect Dis; 2009 Sep; 62(5):343-50. PubMed ID: 19762982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children.
    Tuttle DL; Anders CB; Aquino-De Jesus MJ; Poole PP; Lamers SL; Briggs DR; Pomeroy SM; Alexander L; Peden KW; Andiman WA; Sleasman JW; Goodenow MM
    AIDS Res Hum Retroviruses; 2002 Mar; 18(5):353-62. PubMed ID: 11897037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine model for dengue virus-induced lethal disease with increased vascular permeability.
    Shresta S; Sharar KL; Prigozhin DM; Beatty PR; Harris E
    J Virol; 2006 Oct; 80(20):10208-17. PubMed ID: 17005698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selection of heparin-sensitive dengue virus variants in BHK-21 cells].
    Celis A; Moros Z; Gerder M; Pagano F; Vizzi E; Liprandi F
    Invest Clin; 2014 Jun; 55(2):155-67. PubMed ID: 24974631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of dengue-1 and dengue-4 viruses.
    Chungue E; Cassar O; Drouet MT; Guzman MG; Laille M; Rosen L; Deubel V
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1877-84. PubMed ID: 9049396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of chimeric yellow fever virus-dengue serotype 1-4 virus vaccine strains in dendritic and hepatic cells.
    Brandler S; Brown N; Ermak TH; Mitchell F; Parsons M; Zhang Z; Lang J; Monath TP; Guirakhoo F
    Am J Trop Med Hyg; 2005 Jan; 72(1):74-81. PubMed ID: 15728870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of amino acids in the dengue virus type 2 envelope glycoprotein critical to virus infectivity.
    Kroschewski H; Sagripanti JL; Davidson AD
    J Gen Virol; 2009 Oct; 90(Pt 10):2457-2461. PubMed ID: 19587132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli.
    Jaiswal S; Khanna N; Swaminathan S
    Protein Expr Purif; 2004 Jan; 33(1):80-91. PubMed ID: 14680965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction.
    Johnson BW; Chambers TV; Crabtree MB; Guirakhoo F; Monath TP; Miller BR
    Am J Trop Med Hyg; 2004 Jan; 70(1):89-97. PubMed ID: 14971704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth of dengue type 2 virus isolates in human peripheral blood leukocytes correlates with severe and mild dengue disease.
    Morens DM; Marchette NJ; Chu MC; Halstead SB
    Am J Trop Med Hyg; 1991 Nov; 45(5):644-51. PubMed ID: 1951875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: construction and characterization of mutant viruses.
    Crabtree MB; Kinney RM; Miller BR
    Arch Virol; 2005 Apr; 150(4):771-86. PubMed ID: 15592895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure of the envelope protein domain III of dengue-4 virus.
    Volk DE; Lee YC; Li X; Thiviyanathan V; Gromowski GD; Li L; Lamb AR; Beasley DW; Barrett AD; Gorenstein DG
    Virology; 2007 Jul; 364(1):147-54. PubMed ID: 17395234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bispecific monoclonal antibodies mediate binding of dengue virus to erythrocytes in a monkey model of passive viremia.
    Hahn CS; French OG; Foley P; Martin EN; Taylor RP
    J Immunol; 2001 Jan; 166(2):1057-65. PubMed ID: 11145685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.